Almirall SA (LBTSF)
15.35
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
Almirall EPS Diluted (Quarterly) : 0.1298 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1298 |
| March 31, 2016 | 0.1433 |
| December 31, 2015 | 0.3721 |
| September 30, 2015 | 0.0889 |
| June 30, 2015 | 0.0995 |
| March 31, 2015 | 0.281 |
| December 31, 2014 | 2.923 |
| September 30, 2014 | 0.1856 |
| June 30, 2014 | 0.0686 |
| March 31, 2014 | 0.0822 |
| December 31, 2013 | -0.4356 |
| September 30, 2013 | 0.0265 |
| June 30, 2013 | 0.0522 |
| March 31, 2013 | 0.0792 |
| December 31, 2012 | -0.1167 |
| September 30, 2012 | 0.4751 |
| June 30, 2012 | 0.0642 |
| March 31, 2012 | 0.1442 |
| December 31, 2011 | -0.0404 |
| September 30, 2011 | 0.1694 |
| June 30, 2011 | 0.3308 |
| Date | Value |
|---|---|
| March 31, 2011 | 0.2463 |
| December 31, 2010 | -0.0136 |
| September 30, 2010 | 0.2712 |
| June 30, 2010 | 0.2798 |
| March 31, 2010 | 0.4284 |
| December 31, 2009 | 0.0886 |
| September 30, 2009 | 0.3288 |
| June 30, 2009 | 0.3265 |
| March 31, 2009 | 0.4948 |
| December 31, 2008 | 0.0263 |
| September 30, 2008 | 0.00 |
| June 30, 2008 | 0.00 |
| March 31, 2008 | 0.00 |
| December 31, 2007 | 0.00 |
| September 30, 2007 | 0.00 |
| June 30, 2007 | 0.00 |
| March 31, 2007 | 0.00 |
| December 31, 2006 | 0.00 |
| June 30, 2006 | 0.00 |
| March 31, 2006 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Laboratorios Farmaceúticos Rovi SA | 1.705 |
| Eli Lilly & Co. | 7.939 |
| AstraZeneca PLC | 0.9849 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 28.20M |
| Revenue (Quarterly) | 362.43M |
| Total Expenses (Quarterly) | 334.23M |
| Enterprise Value | 3.304B |
| Gross Profit Margin (Quarterly) | 25.76% |
| Profit Margin (Quarterly) | 7.78% |
| Earnings Yield | 2.08% |
| Operating Earnings Yield | 3.39% |
| Normalized Earnings Yield | 2.03 |